High Content Screening/Imaging: Technologies and Global Markets
商品番号 : SMB-72175
| 出版社 | BCC Research |
| 出版年月 | 2025年1月 |
| ページ数 | 141 |
| 価格タイプ | シングルユーザライセンス |
| 価格 | USD 4,650 |
| 種別 | 英文調査報告書 |
Report Highlights
The global market for high content screening and imaging (HCS/I) is estimated to increase from $3.4 billion in 2024 to reach $5.1 billion by 2029, at a compound annual growth rate (CAGR) of 8.4% from 2024 through 2029.
ハイコンテントスクリーニング／イメージング（HCS/I）の世界市場は、2024 年の 34 億ドルから 2029 年までに 51 億ドルに達し、2024 年から 2029 年までの年間平均成長率（CAGR）は 8.4% になると推定されています。
Summary:
The global market for HCS/I was valued at $3.1 billion in 2023. The market is forecast to grow at a CAGR of 8.4% during the forecast period to reach $5.1 billion by the end of 2029.
Growing pharmaceutical R&D budgets and increasing technological advances in HCS/I are driving the market’s growth. High equipment costs and data management concerns will challenge the market’s growth.
This report sections the global market by component, application, end user and region. By component type, the market is divided into instruments, consumables, software and analytics, and services. The instruments segment, which held the largest share in 2023, is expected to grow at a CAGR of 7.9% during the forecast period.
In terms of applications, the primary and secondary screening segment is forecast to grow at a CAGR of 8.3% during the forecast period. This segment accounted for 32.4% of the market in 2023 and is projected to reach a value of $1.6 billion by the end of 2029.
North America held the largest market share of 37.1% by region in 2023, due to the presence of large pharmaceutical companies and an increasing use of HCS/I by academics in the region.
Leading companies in the global market include Danaher Corp., Revvity Inc., Thermo Fischer Scientific Inc., Agilent Technologies and Yokogawa Electric Corp.
Report Scope
The report offers a detailed picture of the high-content screening/imaging (HCS/I) market.
This report highlights the current and future market potential for HCS/I. It provides a detailed analysis of the competitive environment, regulatory scenario, drivers, restraints, opportunities and trends in the market. The report also covers market projections through 2029 and the market share of key players.
This report discusses the HCS/I industry and its resources. It covers the overall HCS/I market including instruments, consumables (reagents and kits), software and analytics, and services. The report further analyzes the market based on application, analyzing primary and secondary screening, target identification and validation, compound profiling, and toxicity studies. A complete regional analysis of the market is also offered in the report.
The market is segmented by region into North America, Europe, Asia-Pacific and the Rest of the World. Regional analysis is further broken down by country. North America is segmented into the U.S., Canada and Mexico; Europe is segmented into Germany, the U.K., France, Italy, Spain and the Rest of Europe; and Asia-Pacific is segmented into China, Japan, India, South Korea, Australia and the Rest of Asia-Pacific. For market estimates, data has been provided for 2021 and 2022 as the historic years, 2023 as the base year, and forecast for 2024 through 2029.
Report Synopsis
| Report Metrics | Details | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Base year considered | 2023 | ||||||||||||||||
| Forecast period considered | 2024-2029 | ||||||||||||||||
| Base year market size | $3.1 billion | ||||||||||||||||
| Market size forecast | $5.1 billion | ||||||||||||||||
| Growth rate | CAGR of 8.4% for the forecast period of 2024-2029 | ||||||||||||||||
| Units considered | $ Millions | ||||||||||||||||
| Segments covered | Component, Application, End User, Region | ||||||||||||||||
| Regions covered | North America, Europe, Asia-Pacific, Rest of the World | ||||||||||||||||
| Countries covered | U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Belgium, Switzerland, Denmark, Sweden, Norway, Finland, China, India, Japan, Australia, South Korea, Middle East, Africa, and South America | ||||||||||||||||
| Key Market Drivers |
| ||||||||||||||||
| Companies studied |
| ||||||||||||||||
Report Includes
– 56 data tables and 57 additional tables
– Analyses of the trends in global market for high content screening/imaging (HCS/I) technologies, with market revenue data (sales figures) from 2021 and 2022, estimates for 2023, forecasts for 2024, and projected CAGRs through 2029
– Estimates of the market size and revenue growth prospects, along with a market share analysis by component, area of application, end user and region/country
– Facts and figures pertaining to key market dynamics, technological advances, regulations, and the impact of macroeconomic factors
– Insights derived from the Porter’s Five Forces model, as well as global supply chain and PESTLE analyses
– An analysis of patents, emerging trends and developments
– A pricing analysis for HCS/I instruments from leading companies
– Analysis of the industry structure, including companies’ market shares and rankings, strategic alliances, M&A activities, and a venture funding outlook
– Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, and the ESG scores and practices of leading companies
– Company profiles of major players within the industry, including Danaher Corp., Revvity, Thermo Fischer Scientific Inc., Agilent Technologies Inc., and Yokogawa Electric Corp.
Table of Contents
Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Insights
Chapter 2 Market Overview
High-Content Screening Technology Overview
High-Throughput Screening (HTS)
Process Involved in High-Throughput Screening
Developments in HTS
Chapter 3 Market Dynamics
Overview
Market Drivers
Increasing R&D Budgets
Technological Advances in HCS/I
Market Restraints and Challenges
High Equipment Costs
Data Management Challenges
Opportunities in the Market
Opportunities in 3D Applications
Emerging Economies
Chapter 4 Emerging Technologies and Developments
Overview
Emerging Technologies
AI for High-Content Image Analysis
Cell Painting
3D Organoid, Tumoroid and Spheroid Cultures
Chapter 5 Market Segment Analysis
Segmentation Breakdown
Market Analysis by Component
Instruments
Consumables
Software and Analytics
Services
Market Analysis by Application
Primary and Secondary Screening
Target Identification and Validation
Compound Profiling
Toxicity Studies
Other Applications
Market Analysis by End User
Pharmaceutical Companies
Academics
Laboratories and Pathology Centers
Geographic Breakdown
Market Analysis by Region
North America
Europe
Asia-Pacific
Rest of Asia-Pacific
Rest of the World (RoW)
Chapter 6 Competitive Intelligence
Company Share Analysis
Strategic Analysis
Partnerships
Mergers and Acquisitions
Product Launches
Pricing Analysis
Chapter 7 Patent Review
Patent Review
Patent Review by Year
Patent Review by Jurisdiction
Patent Review by Top Applicants
Selected Granted Patents
Chapter 8 Sustainability in the HCS/I Market: An ESG Perspective
ESG Perspective
Environmental Impact
Social Impact
Governance Impact
Understanding the ESG Data
ESG Performance Analysis
Environmental Performance
Social Performance
Governance Performance
Concluding Remarks from BCC
Chapter 9 Appendix
Methodology
Sources
Abbreviations
Company Profiles
AGILENT TECHNOLOGIES INC.
BD
BIO-RAD LABORATORIES INC.
BRUKER
CHARLES RIVER LABORATORIES
CORNING INC.
DANAHER CORP.
EVIDENT
MERCK KGAA
MILTENYI BIOTEC
REVVITY
SARTORIUS AG
THERMO FISHER SCIENTIFIC INC.
YOKOGAWA ELECTRIC CORP.
ZEISS
List of Tables
Summary Table : Global Market for HCS/I, by Region, Through 2029
Table 1 : HTS Detection Methods
Table 2 : R&D Expenditure of Key Pharmaceutical Companies, 2023
Table 3 : Global Market for HCS/I, by Component, Through 2029
Table 4 : Global Market for HCS/I Instruments, by Region, Through 2029
Table 5 : Global Market for HCS/I Instruments, by Type, Through 2029
Table 6 : Selected Imaging Devices Available in the Market
Table 7 : Global Market for Imaging Devices in HCS/I, by Region, Through 2029
Table 8 : Selected Cytometers for Cellomics
Table 9 : Global Market for HCS/I Cytometers, by Region, Through 2029
Table 10 : Global Market for Plate Readers in HCS/I, by Region, Through 2029
Table 11 : Global Market for Light Sources in HCS/I, by Region, Through 2029
Table 12 : Global Market for Detectors and Sensors in HCS/I, by Region, Through 2029
Table 13 : Global Market for Liquid Handling Instruments in HCS/I, by Region, Through 2029
Table 14 : Global Market for HCS/I Consumables, by Region, Through 2029
Table 15 : Global Market for HCS/I Software and Analytics, by Region, Through 2029
Table 16 : Global Market for HCS/I Services, by Region, Through 2029
Table 17 : Global Market for HCS/I, by Application, Through 2029
Table 18 : Global Market for Primary and Secondary Screening Applications in HCS/I, by Region, Through 2029
Table 19 : Global Market for Target Identification and Validation in HCS/I, by Region, Through 2029
Table 20 : Global Market for Compound Profiling in HCS/I, by Region, Through 2029
Table 21 : Toxicology Applications of HCS/I
Table 22 : Global Market for HCS/I in Toxicity Studies, by Region, Through 2029
Table 23 : Global Market for HCS/I in Other Applications, by Region, Through 2029
Table 24 : Global Market for HCS/I, by End User, Through 2029
Table 25 : Global HCS/I Market for Pharmaceutical Companies, by Region, Through 2029
Table 26 : Global HCS/I Market for Academics, by Region, Through 2029
Table 27 : Global HCS/I Market for Laboratories and Pathology Centers, by Region, Through 2029
Table 28 : Global Market for HCS/I, by Region, Through 2029
Table 29 : North American Market for HCS/I, by Country, Through 2029
Table 30 : North American Market for HCS/I, by Component, Through 2029
Table 31 : North American Market for HCS/I Instruments, by Type, Through 2029
Table 32 : North American Market for HCS/I, by Application, Through 2029
Table 33 : North American Market for HCS/I, by End User, Through 2029
Table 34 : European Market for HCS/I, by Country, Through 2029
Table 35 : European Market for HCS/I, by Component, Through 2029
Table 36 : European Market for HCS/I Instruments, by Type, Through 2029
Table 37 : European Market for HCS/I, by Application, Through 2029
Table 38 : European Market for HCS/I, by End User, Through 2029
Table 39 : Asia-Pacific Market for HCS/I, by Country, Through 2029
Table 40 : Asia-Pacific Market for HCS/I, by Component, Through 2029
Table 41 : Asia-Pacific Market for HCS/I Instruments, by Type, Through 2029
Table 42 : Asia-Pacific Market for HCS/I, by Application, Through 2029
Table 43 : Asia-Pacific Market for HCS/I, by End User, Through 2029
Table 44 : RoW Market for HCS/I, by Component, Through 2029
Table 45 : RoW Market for HCS/I Instruments, by Type, Through 2029
Table 46 : RoW Market for HCS/I, by Application, Through 2029
Table 47 : RoW Market for HCS/I, by End User, Through 2029
Table 48 : Selected Strategic Alliances in the HCS/I Industry, 2023 and 2024
Table 49 : Select M&A Activities in the AI in the Cancer Industry, 2024
Table 50 : Product Launches in the HCS/I Industry, 2021-2024
Table 51 : Average Selling Price of HCS/I Products
Table 52 : Selected Patents Issued in HCS/I Industry, 2021-2024
Table 53 : ESG Rankings for Major HCS/I Companies, as of September 2024
Table 54 : ESG: Environmental Overview
Table 55 : ESG: Social Overview
Table 56 : ESG: Governance Overview
Table 57 : Information Sources in this Report
Table 58 : Abbreviations Used in the High Content Screening/Imaging Market
Table 59 : Agilent Technologies Inc.: Company Snapshot
Table 60 : Agilent Technologies Inc.: Financial Performance, FY 2022 and 2023
Table 61 : Agilent Technologies Inc.: Product Portfolio
Table 62 : Agilent Technologies Inc.: News/Key Developments, 2023
Table 63 : BD: Company Snapshot
Table 64 : BD: Financial Performance, FY 2022 and 2023
Table 65 : BD: Product Portfolio
Table 66 : BD: News/Key Developments, 2023
Table 67 : Bio-Rad Laboratories Inc.: Company Snapshot
Table 68 : Bio-Rad Laboratories Inc.: Financial Performance, FY 2022 and 2023
Table 69 : Bio-Rad Laboratories Inc.: Product Portfolio
Table 70 : Bruker: Company Snapshot
Table 71 : Bruker: Financial Performance, FY 2022 and 2023
Table 72 : Bruker: Product Portfolio
Table 73 : Bruker: News/Key Developments, 2024
Table 74 : Charles River Laboratories: Company Snapshot
Table 75 : Charles River Laboratories: Financial Performance, FY 2022 and 2023
Table 76 : Charles River Laboratories: Product Portfolio
Table 77 : Corning Inc.: Company Snapshot
Table 78 : Corning Inc.: Financial Performance, FY 2022 and 2023
Table 79 : Corning Inc.: Product Portfolio
Table 80 : Danaher Corp.: Company Snapshot
Table 81 : Danaher Corp.: Financial Performance, FY 2022 and 2023
Table 82 : Danaher Corp.: Product Portfolio
Table 83 : Danaher Corp.: News/Key Developments, 2021-2024
Table 84 : Evident: Company Snapshot
Table 85 : Evident: Product Portfolio
Table 86 : Evident: News/Key Developments, 2022 and 2023
Table 87 : Merck KGaA: Company Snapshot
Table 88 : Merck KGaA: Financial Performance, FY 2022 and 2023
Table 89 : Merck KGaA: Product Portfolio
Table 90 : Miltenyi Biotec: Company Snapshot
Table 91 : Miltenyi Biotec: Product Portfolio
Table 92 : Miltenyi Biotec: News/Key Developments, 2023 and 2024
Table 93 : Revvity: Company Snapshot
Table 94 : Revvity: Financial Performance, FY 2022 and 2023
Table 95 : Revvity: Product Portfolio
Table 96 : Revvity: News/Key Developments, 2023
Table 97 : Sartorius AG: Company Snapshot
Table 98 : Sartorius AG: Financial Performance, FY 2022 and 2023
Table 99 : Sartorius AG: Product Portfolio
Table 100 : Sartorius AG: News/Key Developments, 2023
Table 101 : Thermo Fisher Scientific Inc.: Company Snapshot
Table 102 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023
Table 103 : Thermo Fisher Scientific Inc.: Product Portfolio
Table 104 : Thermo Fisher Scientific Inc.: News/Key Developments, 2022 and 2023
Table 105 : Yokogawa Electric Corp.: Company Snapshot
Table 106 : Yokogawa Electric Corp.: Financial Performance, FY 2022 and 2023
Table 107 : Yokogawa Electric Corp.: Product Portfolio
Table 108 : Yokogawa Electric Corp.: News/Key Developments, 2024
Table 109 : Zeiss: Company Snapshot
Table 110 : Zeiss: Financial Performance, FY 2022 and 2023
Table 111 : Zeiss: Product Portfolio
Table 112 : Zeiss: News/Key Developments, 2023 and 2024
List of Figures
Summary Figure : Shares of Global Market for HCS/I, by Region, 2023
Figure 1 : HCS Applications
Figure 2 : HCS in Drug Discovery
Figure 3 : Methodology for Data Analysis in the HCS/I Market
Figure 4 : Essential Tools for HCS
Figure 5 : Advantages of HTS
Figure 6 : Applications of High-Throughput Screening
Figure 7 : Market Dynamics of HCS/I Technology
Figure 8 : Technological Advances in HCS
Figure 9 : Emerging Technologies in the HCS/I Market
Figure 10 : Shares of Global Market for HCS/I, by Component, 2023
Figure 11 : Global Market for HCS/I, by Region, 2021-2029
Figure 12 : Global Market for HCS/I Instruments, 2021-2029
Figure 13 : Shares of Global Market for HCS/I Instruments, by Type, 2023
Figure 14 : Microplate Reader Categories
Figure 15 : Global Market for HCS/I Consumables, 2021-2029
Figure 16 : General Steps Involved in HCS/I Software Analysis
Figure 17 : Global Market for HCS/I Software and Analytics, 2021-2029
Figure 18 : Global Market for HCS/I Services, 2021-2029
Figure 19 : Shares of Global Market for HCS/I, by Application, 2023
Figure 20 : Features of a Lead Compound
Figure 21 : Global Market for Primary and Secondary Screening Applications in HCS/I, 2021-2029
Figure 22 : Global Market for Target Identification and Validation in HCS/I, 2021-2029
Figure 23 : Strategies to Improve Screening Using Compound Profiling
Figure 24 : Global Market for Compound Profiling in HCS/I, 2021-2029
Figure 25 : Global Market for HCS/I in Toxicity Studies, 2021-2029
Figure 26 : Global Market for HCS/I in Other Applications, 2021-2029
Figure 27 : Global Market Shares of HCS/I, by End User, 2023
Figure 28 : Global HCS/I Market for Pharmaceutical Companies, 2021-2029
Figure 29 : Global HCS/I Market for Academics, 2021-2029
Figure 30 : Global HCS/I Market for Laboratories and Pathology Centers, 2021-2029
Figure 31 : Shares of Global Market for HCS/I, by Region, 2023
Figure 32 : Global Market for HCS/I, by Region, 2021-2029
Figure 33 : Shares of North American Market for HCS/I, by Country, 2023
Figure 34 : U.S. Market for HCS/I, 2021-2029
Figure 35 : Canadian Market for HCS/I, 2021-2029
Figure 36 : Mexican Market for HCS/I, 2021-2029
Figure 37 : European Market Shares of HCS/I, by Country, 2023
Figure 38 : German Market for HCS/I, 2021-2029
Figure 39 : French Market for HCS/I, 2021-2029
Figure 40 : Italian Market for HCS/I, 2021-2029
Figure 41 : Spanish Market for HCS/I, 2021-2029
Figure 42 : U.K. Market for HCS/I, 2021-2029
Figure 43 : Rest of European Market for HCS/I, 2021-2029
Figure 44 : Shares of Asia-Pacific Market for HCS/I, by Country, 2023
Figure 45 : Chinese Market for HCS/I, 2021-2029
Figure 46 : Japanese Market for HCS/I, 2021-2029
Figure 47 : Indian Market for HCS/I, 2021-2029
Figure 48 : South Korean Market for HCS/I, 2021-2029
Figure 49 : Australian Market for HCS/I, 2021-2029
Figure 50 : Rest of Asia-Pacific Market for HCS/I, 2021-2029
Figure 51 : Shares of Global Market for HCS/I, by Company, 2023
Figure 52 : Strategies Adopted by Companies in the HCS/I Industry
Figure 53 : Granted HCS/I Patents, by Year, 2021-2024
Figure 54 : Granted HCS/I Patents, by Jurisdiction, 2021-2024
Figure 55 : Top Applicants for Granted HCS/I Patents, 2021-2024
Figure 56 : Agilent Technologies Inc.: Revenue Share, by Business Unit, FY 2023
Figure 57 : Agilent Technologies Inc.: Revenue Share, by Country/Region, FY 2023
Figure 58 : BD: Revenue Share, by Business Unit, FY 2023
Figure 59 : BD: Revenue Share, by Country/Region, FY 2023
Figure 60 : Bio-Rad Laboratories Inc.: Revenue Share, by Business Unit, FY 2023
Figure 61 : Bio-Rad Laboratories Inc.: Revenue Share, by Country/Region, FY 2023
Figure 62 : Bruker: Revenue Share, by Business Unit, FY 2023
Figure 63 : Bruker: Revenue Share, by Country/Region, FY 2023
Figure 64 : Charles River Laboratories: Revenue Share, by Business Unit, FY 2023
Figure 65 : Charles River Laboratories: Revenue Share, by Country/Region, FY 2023
Figure 66 : Corning Inc.: Revenue Share, by Business Unit, FY 2023
Figure 67 : Corning Inc.: Revenue Share, by Country/Region, FY 2023
Figure 68 : Danaher Corp.: Revenue Share, by Business Unit, FY 2023
Figure 69 : Danaher Corp.: Revenue Share, by Country/Region, FY 2023
Figure 70 : Merck KGaA: Revenue Share, by Business Unit, FY 2023
Figure 71 : Merck KGaA: Revenue Share, by Country/Region, FY 2023
Figure 72 : Revvity: Revenue Share, by Business Unit, FY 2023
Figure 73 : Revvity: Revenue Share, by Country/Region, FY 2023
Figure 74 : Sartorius AG: Revenue Share by Business Unit, FY 2023
Figure 75 : Sartorius AG: Revenue Share, by Country/Region, FY 2023
Figure 76 : Thermo Fisher Scientific Inc.: Revenue Share, by Business Unit, FY 2023
Figure 77 : Thermo Fisher Scientific Inc.: Revenue Share, by Country/Region, FY 2023
Figure 78 : Yokogawa Electric Corp.: Revenue Share, by Business Unit, FY 2023
Figure 79 : Yokogawa Electric Corp.: Revenue Share, by Country/Region, FY 2023
Figure 80 : Zeiss: Revenue Share, by Business Unit, FY 2023
Figure 81 : Zeiss: Revenue Share, by Country/Region, FY 2023
BCC Research（BCCリサーチ）はライフサイエンス、センサ、マテリアル、環境、商取引関連市場を中心とした広範な市場調査レポートを出版する米国の調査会社です。
ライセンス別価格表
2024年11月より価格構成が大幅に変更になりました。最新の価格についてはお問合せください。
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
新価格表
ライセンスタイプ1
| シングルユーザ | 2-5ユーザ | サイト | エンタープライズ |
| USD 4,650 | USD 5,580 | USD 6,696 | USD 8,035 |
ライセンスタイプ2
| シングルユーザ | 2-5ユーザ | サイト | エンタープライズ |
| USD 2,950 | USD 3,540 | USD 4,248 | USD 5,098 |
ライセンスタイプ3
| シングルユーザ | 2-5ユーザ | サイト | エンタープライズ |
| USD 2,500 | USD 3,000 | USD 3,600 | USD 4,320 |
旧価格表
旧ライセンスタイプ1
| シングルユーザ | 2-5ユーザ | サイト | エンタープライズ |
| USD 5,500 | USD 6,600 | USD7.920 | USD 9,504 |
旧ライセンスタイプ2
| シングルユーザ | 2-5ユーザ | サイト | エンタープライズ |
| USD 3,500 | USD 4,200 | USD 5,040 | USD 6,048 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
- ライセンス
- シングルユーザライセンス
- 1名のみレポートファイルのご利用が可能です。
- 2-5ライセンス
- 同一企業内5名までレポートファイルのご利用が可能です。
- サイトライセンス
- 同一企業同住所内でレポートファイルのご利用が可能です。
- エンタープライズライセンス
- 同一企業内人数無制限でレポートファイルのご利用が可能です。
- シングルユーザライセンス
- 納品形態
- Eメール
- 納期
- ご注文後3営業日以内
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
BCC Researchが出版する調査レポートのサンプルページのご依頼、見積り、ご質問など購入前のご相談はいつでもお気軽にご連絡ください。
最新調査レポート
- 食品小売業およびEコマースにおけるAIの世界市場 2025-11-14
- 免疫療法薬の世界市場 2025-11-12
- 農業におけるAIの世界市場 2025-11-10
- 固体酸化物形燃料電池の技術と世界市場 2025-11-07
- 世界の電気アーク炉市場 2025-11-07
